EurekAlert!

Cedars-Sinai certified by ALS Association as Center of Excellence for treatment, research

LOS ANGELES (Sept. 30, 2014) – The ALS Program at Cedars-Sinai has become the first in Southern California to be named an ALS Association Certified Treatment Center of Excellence – a distinction that ...
Nasdaq

Voyager Provides Update on SOD1 ALS Gene Therapy Program

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...
MM&M

Takeda places $580M bet on AcuraStem’s ALS treatments

Takeda Pharmaceuticals struck a deal with AcuraStem to purchase its amyotrophic lateral sclerosis (ALS) treatment program on Monday. Per terms of the transaction, the Japanese pharma giant will ...
Business Wire

Team Gleason Donates $750,000 To Expand Boston Children’s Hospital’s ALS Augmentative Communication Program. This Five-year Collaboration Will Provide Services to People ...

NEW ORLEANS & BOSTON--(BUSINESS WIRE)--Team Gleason, a leading foundation for ALS patient support, is collaborating with Boston Children’s Hospital’s ALS Augmentative Communication Program, which ...
Nasdaq

Clene to Provide CNM-Au8® ALS Program Update

SALT LAKE CITY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage ...
Yahoo Finance

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today ...